Sanofi delivers strong Q1 2019 business EPS growth of 9.4% at CER
- Written by ACN Newswire
PARIS, FRANCE, Apr 26, 2019 - (ACN Newswire) - Sanofi delivered strong Q1 2019 business EPS growth of 9.4% at CER.First-quarter sales growth driven by Specialty Care, Vaccines and strong contribution from Emerging Markets* Net sales were EUR8,391 million, an increase of 6.2% on a reported basis, 4.2% at CER and 3.8% at CER/CS.* Sanofi Genzyme GBU...